Virus Activated Killer Immune Cells (Binhui )

N/A

Report date: 2022/12/27 09:23:01

Base Information

Drug NameVirus Activated Killer Immune Cells (Binhui )
Drug Alias NameVirus Activated Killer Immune Cells (VAK)(Binhui )
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsAscitesPleural Effusion, Malignant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuhan Binhui Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Binhui Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsAscitesPleural Effusion, Malignant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A